|
End-of-day quote
Shanghai S.E.
29/10/2026
|
5-day change | 1st Jan Change | ||
| 5.150 CNY | -0.39% |
|
+4.67% | +0.59% |
| 10-23 | Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2026 | CI |
| 10-21 | Jointown Pharmaceutical Completes Repayment of 300-Million-Yuan Bonds | MT |
Company Valuation: Jointown Pharmaceutical Group Co., Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 26,919 | 24,052 | 26,691 | 25,148 | 25,531 | 25,680 | - | - |
| Change | - | -10.65% | 10.97% | -5.78% | 1.52% | 0.59% | - | - |
| Enterprise Value (EV) 1 | 29,021 | 21,882 | 24,319 | 20,414 | 20,954 | 21,736 | 20,917 | 21,340 |
| Change | - | -24.6% | 11.14% | -16.06% | 2.65% | 3.73% | -3.77% | 2.02% |
| P/E | 11.6x | 12.2x | 12.7x | 10.2x | 11.6x | 10.8x | 10x | 9.04x |
| PBR | 1.31x | 1.09x | 1.14x | 0.95x | 0.96x | 0.88x | 0.83x | 0.79x |
| PEG | - | -0.8x | 1.76x | 0.6x | -1x | 1.27x | 1.36x | 0.8x |
| Capitalization / Revenue | 0.22x | 0.17x | 0.18x | 0.17x | 0.16x | 0.15x | 0.14x | 0.13x |
| EV / Revenue | 0.24x | 0.16x | 0.16x | 0.13x | 0.13x | 0.12x | 0.11x | 0.11x |
| EV / EBITDA | 6.93x | 6.21x | 6.5x | 4.61x | 5.18x | 4.16x | 3.87x | 3.51x |
| EV / EBIT | 8.08x | 7.67x | 8.05x | 5.62x | 6.34x | 5.29x | 5.46x | 4.99x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.1115 | 0.1858 | 0.1938 | 0.2 | 0.2 | 0.1851 | 0.2196 | 0.2482 |
| Rate of return | 2.04% | 3.83% | 3.57% | 3.91% | 3.91% | 3.59% | 4.27% | 4.82% |
| EPS 2 | 0.472 | 0.3976 | 0.4264 | 0.5 | 0.44 | 0.4775 | 0.5125 | 0.57 |
| Distribution rate | 23.6% | 46.7% | 45.5% | 40% | 45.5% | 38.8% | 42.9% | 43.5% |
| Net sales 1 | 122,407 | 140,424 | 150,140 | 151,810 | 161,390 | 174,339 | 182,189 | 192,291 |
| EBITDA 1 | 4,187 | 3,526 | 3,741 | 4,427 | 4,046 | 5,228 | 5,406 | 6,074 |
| EBIT 1 | 3,593 | 2,853 | 3,023 | 3,635 | 3,306 | 4,111 | 3,831 | 4,275 |
| Net income 1 | 2,448 | 2,085 | 2,174 | 2,507 | 2,255 | 1,972 | 2,511 | 2,763 |
| Net Debt 1 | 2,102 | -2,170 | -2,372 | -4,734 | -4,576 | -3,944 | -4,763 | -4,340 |
| Reference price 2 | 5.470 | 4.846 | 5.434 | 5.120 | 5.120 | 5.150 | 5.150 | 5.150 |
| Nbr of stocks (in thousands) | 4,921,006 | 4,963,416 | 4,911,693 | 4,911,693 | 4,986,434 | 4,986,434 | - | - |
| Announcement Date | 25/04/22 | 24/04/23 | 26/04/24 | 28/04/25 | 27/04/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 10.79x | 0.12x | 4.16x | 3.6% | 3.85B | ||
| 40.35x | 13.85x | 30.26x | 0.5% | 1,224B | ||
| 40.28x | 6.76x | 19.02x | 1.94% | 662B | ||
| 38.08x | 8.51x | 17.61x | 2.36% | 514B | ||
| 21.65x | 5.25x | 13.07x | 2.49% | 388B | ||
| 106.67x | 5.95x | 25.48x | 2.33% | 361B | ||
| 22.86x | 5.89x | 14.22x | 2.75% | 302B | ||
| 22.82x | 4.6x | 13.15x | 1.92% | 271B | ||
| 29.23x | 7.45x | 13.34x | 2.19% | 249B | ||
| -47.64x | 7.37x | 28.55x | 1.99% | 205B | ||
| Average | 28.51x | 6.58x | 17.89x | 2.21% | 418.07B | |
| Weighted average by Cap. | 36.64x | 8.70x | 21.53x | 1.73% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 600998 Stock
- Valuation Jointown Pharmaceutical Group Co., Ltd
Select your edition
All financial news and data tailored to specific country editions
















